Drug Type Small molecule drug |
Synonyms 西洛他唑/冰片 + [1] |
Target |
Action inhibitors |
Mechanism PDE3 inhibitors(Phosphodiesterase 3 inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePhase 2 |
First Approval Date- |
Regulation- |
Molecular FormulaC10H22O |
InChIKeyMWKFXSUHUHTGQN-UHFFFAOYSA-N |
CAS Registry112-30-1 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
occlusions | Phase 2 | - | 01 Nov 2023 | |
Acute Ischemic Stroke | Phase 2 | China | 05 Jun 2023 | |
Cognition Disorders | Preclinical | China | 01 Dec 2024 |